Cargando…
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients
BACKGROUND: Diabetes is a risk factor for the progression and prognosis of coronavirus disease (COVID-19), but the relationship between glycosylated hemoglobin (HbA1c) level, inflammation, and prognosis of COVID-19 patients has not been explored. METHODS: This was a retrospective study of COVID-19 p...
Autores principales: | Wang, Zhenzhou, Du, Zhe, Zhu, Fengxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233217/ https://www.ncbi.nlm.nih.gov/pubmed/32416121 http://dx.doi.org/10.1016/j.diabres.2020.108214 |
Ejemplares similares
-
Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable
state
por: Insausti-García, Alfredo, et al.
Publicado: (2020) -
Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose
por: Wang, Zhenzhou, et al.
Publicado: (2021) -
Hemoglobin E disease and glycosylated hemoglobin
por: Yedla, Niharika, et al.
Publicado: (2015) -
The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022) -
Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)